Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection
- 31 January 2007
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 87 (1) , 223-226
- https://doi.org/10.1016/j.fertnstert.2006.06.019
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Influence of embryo quality and number of previous cycles on pregnancy and multiple pregnancy rates in women aged 35 to 37 years who received two or three embryosFertility and Sterility, 2005
- Anti-Müllerian hormone and folliculogenesisMolecular and Cellular Endocrinology, 2005
- Anti‐müllerian hormone as a marker of ovarian reserve*Australian and New Zealand Journal of Obstetrics and Gynaecology, 2005
- Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiolFertility and Sterility, 2004
- Anti-Müllerian hormone and its role in ovarian functionMolecular and Cellular Endocrinology, 2003
- Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysisFertility and Sterility, 2003
- Müllerian Inhibitory Substance Induces Growth of Rat Preantral Ovarian Follicles1Biology of Reproduction, 2001
- Serum müllerian-inhibiting substance levels during normal menstrual cyclesFertility and Sterility, 2000
- Use of the Antral Follicle Count to Predict the Outcome of Assisted Reproductive TechnologiesFertility and Sterility, 1998
- Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcomeFertility and Sterility, 1997